Smad6 and Smad7 are co-regulated with hepcidin in mouse models of iron overload

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 1, 2013, Pages 76-84

  Vujić Spasić, Maja ^a   Sparla, Richard ^a   Mleczko Sanecka, Katarzyna ^a   Migas, Mary C ^b   Breitkopf Heinlein, Katja ^c   Dooley, Steven ^c   Vaulont, Sophie ^d   Fleming, Robert E ^b   Muckenthaler, Martina U ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d INSERM   (France)

Author keywords

Bmp Smad; Hemochromatosis; Hepcidin; Iron; Smad6; Smad7

Indexed keywords

HEMOJUVELIN; HEPCIDIN; HEPCIDIN 1; HFE PROTEIN; IRON DEXTRAN; MESSENGER RNA; SMAD6 PROTEIN; SMAD7 PROTEIN; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HUMAN; HUMAN CELL; IRON OVERLOAD; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; DISEASE MODELS, ANIMAL; FEMALE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TRANSFERRIN; SMAD6 PROTEIN; SMAD7 PROTEIN;

MUS;

EID: 84868560392     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.08.013     Document Type: Article

References (35)

1. Andrews N.C. Iron homeostasis: insights from genetics and animal models. Nat. Rev. Genet. 2000, 1:208-217.
2. Lesbordes-Brion J.C., Viatte L., Bennoun M., Lou D.Q., Ramey G., Houbron C., Hamard G., Kahn A., Vaulont S. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 2006, 108:1402-1405.
3. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo R., Ellis M.C., Fullan A., Hinton L.M., Jones N.L., Kimmel B.E., Kronmal G.S., Lauer P., Lee V.K., Loeb D.B., Mapa F.A., McClelland E., Meyer N.C., Mintier G.A., Moeller N., Moore T., Morikang E., Prass C.E., Quintana L., Starnes S.M., Schatzman R.C., Brunke K.J., Drayna D.T., Risch N.J., Bacon B.R., Wolff R.K. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 1996, 13:399-408.
4. Bridle K.R., Frazer D.M., Wilkins S.J., Dixon J.L., Purdie D.M., Crawford D.H., Subramaniam V.N., Powell L.W., Anderson G.J., Ramm G.A. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003, 361:669-673.
5. Wallace D.F., Summerville L., Crampton E.M., Frazer D.M., Anderson G.J., Subramaniam V.N. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 2009, 50:1992-2000.
6. Wallace D.F., Summerville L., Subramaniam V.N. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. Gastroenterology 2007, 132:301-310.
7. Kawabata H., Fleming R.E., Gui D., Moon S.Y., Saitoh T., O'Kelly J., Umehara Y., Wano Y., Said J.W., Koeffler H.P. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 2005, 105:376-381.
8. Niederkofler V., Salie R., Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J. Clin. Invest. 2005, 115:2180-2186.
9. Huang F.W., Pinkus J.L., Pinkus G.S., Fleming M.D., Andrews N.C. A mouse model of juvenile hemochromatosis. J. Clin. Invest. 2005, 115:2187-2191.
10. Kautz L., Meynard D., Besson-Fournier C., Darnaud V., Al Saati T., Coppin H., Roth M.P. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. Blood 2009, 114:2515-2520.
11. Corradini E., Garuti C., Montosi G., Ventura P., Andriopoulos B., Lin H.Y., Pietrangelo A., Babitt J.L. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis. Gastroenterology 2009, 137:1489-1497.
12. Ryan J.D., Ryan E., Fabre A., Lawless M.W., Crowe J. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis. Hepatology 2010, 52:1266-1273.
13. Corradini E., Rozier M., Meynard D., Odhiambo A., Lin H.Y., Feng Q., Migas M.C., Britton R.S., Babitt J.L., Fleming R.E. Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 2011, 141(5):1907-1914.
14. Babitt J.L., Huang F.W., Wrighting D.M., Xia Y., Sidis Y., Samad T.A., Campagna J.A., Chung R.T., Schneyer A.L., Woolf C.J., Andrews N.C., Lin H.Y. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 2006, 38:531-539.
15. Zhang A.S., Gao J., Koeberl D.D., Enns C.A. The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo. J. Biol. Chem. 2010, 285:16416-16423.
16. Andriopoulos B., Corradini E., Xia Y., Faasse S.A., Chen S., Grgurevic L., Knutson M.D., Pietrangelo A., Vukicevic S., Lin H.Y., Babitt J.L. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 2009, 41:482-487.
17. Meynard D., Kautz L., Darnaud V., Canonne-Hergaux F., Coppin H., Roth M.P. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat. Genet. 2009, 41:478-481.
18. Wang R.H., Li C., Xu X., Zheng Y., Xiao C., Zerfas P., Cooperman S., Eckhaus M., Rouault T., Mishra L., Deng C.X. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2005, 2:399-409.
19. Miyazono K., Maeda S., Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005, 16:251-263.
20. Afrakhte M., Moren A., Jossan S., Itoh S., Sampath K., Westermark B., Heldin C.H., Heldin N.E., Ten Dijke P. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem. Biophys. Res. Commun. 1998, 249:505-511.
21. Itoh S., Ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr. Opin. Cell Biol. 2007, 19:176-184.
22. Ulloa L., Doody J., Massague J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 1999, 397:710-713.
23. Bitzer M., von Gersdorff G., Liang D., Dominguez-Rosales A., Beg A.A., Rojkind M., Bottinger E.P. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 2000, 14:187-197.
24. Kautz L., Meynard D., Monnier A., Darnaud V., Bouvet R., Wang R.H., Deng C., Vaulont S., Mosser J., Coppin H., Roth M.P. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008, 112:1503-1509.
25. Corradini E., Meynard D., Wu Q., Chen S., Ventura P., Pietrangelo A., Babitt J.L. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 2011, 54:273-284.
26. Mleczko-Sanecka K., Casanovas G., Ragab A., Breitkopf K., Muller A., Boutros M., Dooley S., Hentze M.W., Muckenthaler M.U. SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. Blood 2010, 115:2657-2665.
27. Vujic Spasic M., Kiss J., Herrmann T., Kessler R., Stolte J., Galy B., Rathkolb B., Wolf E., Stremmel W., Hentze M.W., Muckenthaler M.U. Physiological systemic iron metabolism in mice deficient for duodenal Hfe. Blood 2007, 109:4511-4517.
28. Muckenthaler M., Roy C.N., Custodio A.O., Minana B., deGraaf J., Montross L.K., Andrews N.C., Hentze M.W. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat. Genet. 2003, 34:102-107.
29. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:e36.
30. Klingmuller U., Bauer A., Bohl S., Nickel P.J., Breitkopf K., Dooley S., Zellmer S., Kern C., Merfort I., Sparna T., Donauer J., Walz G., Geyer M., Kreutz C., Hermes M., Gotschel F., Hecht A., Walter D., Egger L., Neubert K., Borner C., Brulport M., Schormann W., Sauer C., Baumann F., Preiss R., MacNelly S., Godoy P., Wiercinska E., Ciuclan L., Edelmann J., Zeilinger K., Heinrich M., Zanger U.M., Gebhardt R., Maiwald T., Heinrich R., Timmer J., von Weizsacker F., Hengstler J.G. Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst. Biol. (Stevenage) 2006, 153:433-447.
31. Ludwiczek S., Theurl I., Artner-Dworzak E., Chorney M., Weiss G. Duodenal HFE expression and hepcidin levels determine body iron homeostasis: modulation by genetic diversity and dietary iron availability. J. Mol. Med. 2004, 82:373-382.
32. Camaschella C. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 2005, 106:3710-3717.
33. Bolondi G., Garuti C., Corradini E., Zoller H., Vogel W., Finkenstedt A., Babitt J.L., Lin H.Y., Pietrangelo A. Altered hepatic BMP signaling pathway in human HFE hemochromatosis. Blood Cells Mol. Dis. 2010, 45:308-312.
34. Ramos E., Kautz L., Rodriguez R., Hansen M., Gabayan V., Ginzburg Y., Roth M.P., Nemeth E., Ganz T. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology. 2011, 53:1333-1341.
35. Moren A., Imamura T., Miyazono K., Heldin C.H., Moustakas A. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J. Biol. Chem. 2005, 280:22115-22123.